Authors:
BEVERIDGE RA
MILLER JA
KALES AN
BINDER RA
ROBERT NJ
HARVEY JH
WINDSOR K
GORE I
CANTRELL J
THOMPSON KA
TAYLOR WR
BARNES HM
SCHIFF SA
SHIELDS JA
CAMBARERI RJ
BUTLER TP
MEISTER RJ
FEIGERT JM
NORGARD MJ
MORAES MA
HELVIE WW
PATTON GA
MUNDY LJ
HENRY D
MASON B
STADDON A
FORD P
KATCHER D
HOUCK W
MAJOR WB
GEMMA NW
KAY G
PRIEST E
SOWROY P
BANK B
LEIBACH S
REISEL H
GRAD G
WARREN RD
UENO WM
SMITH LF
DOBRZYNSKI RF
SHERIDAN MJ
Citation: Ra. Beveridge et al., A COMPARISON OF EFFICACY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN THE THERAPEUTIC SETTING OFCHEMOTHERAPY-INDUCED MYELOSUPPRESSION, Cancer investigation, 16(6), 1998, pp. 366-373
Authors:
TAYLOR CW
GREEN S
DALTON WS
MARTINO S
RECTOR D
INGLE JN
ROBERT NJ
BUDD GT
PARADELO JC
NATALE RB
BEARDEN JD
MAILLIARD JA
OSBORNE CK
Citation: Cw. Taylor et al., A MULTICENTER RANDOMIZED CLINICAL-TRIAL OF GOSERELIN VERSUS SURGICAL OVARIECTOMY IN PREMENOPAUSAL PATIENTS WITH RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - AN INTERGROUP STUDY, Journal of clinical oncology, 16(3), 1998, pp. 994-999
Authors:
BEVERIDGE RA
MILLER JA
KALES AN
BINDER RA
ROBERT NJ
HEISRATHEVANS J
KOCZYKSCRIPKA K
PASHKO S
NORGARD MJ
BARNES HM
TAYLOR WR
THOMPSON KA
SMITH LF
UENO WM
DOBRZYNSKI RF
WARREN RD
KATCHER D
BYRNE PJ
DUNNING DM
WINOKUR SH
LOCKEY JL
CAMBARERI RJ
BUTLER TP
MEISTER RJ
FIEGERT JM
Citation: Ra. Beveridge et al., RANDOMIZED TRIAL COMPARING THE TOLERABILITY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN CANCER-PATIENTS RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY, Supportive care in cancer, 5(4), 1997, pp. 289-298
Authors:
SPARANO JA
NEUBERG D
GLICK JH
ROBERT NJ
GOLDSTEIN LJ
SLEDGE GW
WOOD W
Citation: Ja. Sparano et al., PHASE-II TRIAL OF BIWEEKLY PACLITAXEL AND CISPLATIN IN ADVANCED BREAST-CARCINOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(5), 1997, pp. 1880-1884
Authors:
ISAACS C
ROBERT NJ
BAILEY FA
SCHUSTER MW
OVERMOYER B
GRAHAM M
CAI B
BEACH KJ
LOEWY JW
KAYE JA
Citation: C. Isaacs et al., RANDOMIZED PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 TO PREVENT CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH BREAST-CANCER RECEIVING DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN, Journal of clinical oncology, 15(11), 1997, pp. 3368-3377
Authors:
COBLEIGH MA
BERRIS RF
BUSH T
DAVIDSON NE
ROBERT NJ
SPARANO JA
TORMEY DC
WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - REPLY, JAMA, the journal of the American Medical Association, 273(8), 1995, pp. 621-621
Authors:
COBLEIGH MA
BERRIS RF
BUSH T
DAVIDSON NE
ROBERT NJ
SPARANO JA
TORMEY DC
WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE (VOL 272, PG 540, 1994), JAMA, the journal of the American Medical Association, 273(5), 1995, pp. 378-378
Citation: Nj. Robert et Ra. Beveridge, MANAGEMENT OF RECURRENT BREAST-CANCER, Obstetrics and gynecology clinics of North America, 21(4), 1994, pp. 709-719
Authors:
COBLEIGH MA
BERRIS RF
BUSH T
DAVIDSON NE
ROBERT NJ
SPARANO JA
TORMEY DC
WOOD WC
Citation: Ma. Cobleigh et al., ESTROGEN REPLACEMENT THERAPY IN BREAST-CANCER SURVIVORS - A TIME FOR CHANGE, JAMA, the journal of the American Medical Association, 272(7), 1994, pp. 540-545
Authors:
WAZER DE
ERBAN JK
ROBERT NJ
SMITH TJ
MARCHANT DJ
SCHMID C
DIPETRILLO T
SCHMIDTULLRICH R
Citation: De. Wazer et al., BREAST-CONSERVATION IN ELDERLY WOMEN FOR CLINICALLY NEGATIVE AXILLARYLYMPH-NODES WITHOUT AXILLARY DISSECTION, Cancer, 74(3), 1994, pp. 878-883
Authors:
LONDON SJ
SACKS FM
STAMPFER MJ
HENDERSON IC
MACLURE M
TOMITA A
WOOD WC
REMINE S
ROBERT NJ
DMOCHOWSKI JR
WILLETT WC
Citation: Sj. London et al., FATTY-ACID COMPOSITION OF THE SUBCUTANEOUS ADIPOSE-TISSUE AND RISK OFPROLIFERATIVE BENIGN BREAST DISEASE AND BREAST-CANCER, Journal of the National Cancer Institute, 85(10), 1993, pp. 785-793
Authors:
SAPHNER T
TROXEL AB
TORMEY DC
NEUBERG D
ROBERT NJ
PANDYA KJ
EDMONSON JH
ROSENBLUTH RJ
ABELOFF MD
Citation: T. Saphner et al., PHASE-II STUDY OF GOSERELIN FOR PATIENTS WITH POSTMENOPAUSAL METASTATIC BREAST-CANCER, Journal of clinical oncology, 11(8), 1993, pp. 1529-1535
Authors:
KRONTIRIS TG
DEVLIN B
KARP DD
ROBERT NJ
RISCH N
Citation: Tg. Krontiris et al., AN ASSOCIATION BETWEEN THE RISK OF CANCER AND MUTATIONS IN THE HRAS1 MINISATELLITE LOCUS, The New England journal of medicine, 329(8), 1993, pp. 517-523
Authors:
SPARANO JA
WADLER S
LIEBES L
ROBERT NJ
SCHWARTZ EL
DUTCHER JP
Citation: Ja. Sparano et al., PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER, Cancer research, 53(15), 1993, pp. 3509-3512